Home > Ad Gallery > Pharmaceutical Product ads > Canada > HCP - Canada > Depression-Bipolarity
The full-size photo is available to registered users. Registration is free.
Cymbalta It is estimated that over 13.5 million patients have been treated worldwide
Duloxetine (brand names Cymbalta, Yentreve) is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for major depressive disorder (MDD), generalized anxiety disorder (GAD), pain related to diabetic neuropathy and fibromyalgia and in some countries for stress urinary incontinence (SUI). It is manufactured and marketed by Eli Lilly. Large number of side effects occurring during duloxetine treatment and lack of clear advantage over existing medications prompted critical reviews concluding that duloxetine "should not be used" for stress urinary incontinence and "currently has no place in the treatment of depression or diabetic neuropathy" as well.

On Wikipedia
Effexor2.jpg Cymbalta-MedPost080909.jpg JournPsychAndNeuroscienceInvega.jpg
Rate this file (No vote yet)
Rubbish
Poor
Fair
Good
Excellent
Great
File information
Album name:admin / Depression-Bipolarity
Keywords:Boehringer Ingelheim Lilly Canada Cymbalta depression symptomatic relief of major depressive disorder MDD fibromyalgia FM HCP The Medical Post September 2008 single-page ad
Country:Canada
Source:The Medical Post
File Size:1177 KB
Date added:Sep 11, 2008
Dimensions:2102 x 3308 pixels
Displayed:30 times
URL:http://adpharm.net/displayimage-10764.html
Favorites:Add to Favorites



Green Web Hosting! This site hosted by DreamHost.